BERLIN — Six European countries have ordered a temporary ban on the import or use of some Novartis flu vaccines.

Austria, France, Germany, Italy, Spainm and Switzerland have limited the use of Fluad or Aggripal, or both, after the company reported the appearance of small particles in the vaccine to Italian authorities.

Italian health officials say the company knew of the problem since July but only notified them this month.

Novartis spokesman Eric Althoff declined to specify Friday how long the Basel, Switzerland-based pharmaceutical giant waited before telling authorities.

In an email, Althoff said that "once the deviation was seen, an investigation was started and the findings were shared with the Italian Ministry of Health."

Other flu vaccines are available in the affected countries but delivery bottlenecks are expected in some regions.